CRA consultants supported a pharmaceutical company in its successful challenge of an ANDA filed by a generic manufacturer. The generic company sought to manufacture and sell generic versions of two related diabetes treatments. CRA provided a report analyzing evidence of commercial success for the branded pharmaceutical products as well as deposition and trial testimony.
Update on the Texas Business Court: July 2025
The Texas Business Court was formed in September 2024 as a specialized court that aims to provide a more efficient and predictable environment for resolving...